- Pharma is betting big on PD-1/VEGF bispecifics. But are companies chasing the wrong target?<figure><div><img src="https://imgproxy.divecdn.com/xbHcBuJpB2jn4XdBnacn9EL1qH4IPhhgp3V92WERlvI/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9TY3JlZW5zaG90XzIwMjYtMDYtMDNfYXRfM…BioPharma Dive · 1mo ago↗ source
- Otsuka touts new IgAN evidence as it seeks full approval for VoyxactOtsuka Pharmaceutical reported new evidence on Thursday that it thinks will help support a full approval for its monoclonal antibody Voyxact in a chronic autoimmune disease that affects the kidneys…Endpoints · 1mo ago↗ source
- Acting FDA chief isn't interested in permanent roleActing FDA Commissioner Kyle Diamantas isn't interested in keeping the job and the search for a permanent replacement is progressing, according to a source familiar with the process. An announcem…